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Abstract
Background: Degraded extracellular matrix can stimulate the innate immune system via the Toll-Like Receptor-4
(TLR4). In the pancreas, syndecan-anchored heparan sulphate (HS) on the ductal epithelium can be cleaved off its
protein cores by the proteases (trypsin and elastase) and potentially activate TLR4 signalling.
Methods: To investigate this signalling event, a low sulphated HS (500 μg/ml) was infused into the biliary-
pancreatic duct of C57BL/6J wild-type mice. Phosphate buffered saline (PBS) and lipopolysaccharide (LPS) were
used as negative and positive controls, respectively. Mice were sacrificed after 1, 3, 6, 9, and 48 hours and tissues
were analysed for neutrophil and cytokine contents. In order to study the TLR4 signalling pathway of HS in the
pancreas, genetically engineered mice lacking TLR4, Myeloid Differentiation primary response gene (88) (MyD88) or
Interferon Regulatory Factor 3 (IRF3) were subjected to pancreatic infusion of HS.
Results: Neutrophil sequestration and corresponding myeloperoxidase (MPO) activity in the pancreas were
increased 9 hours following HS challenge. In wild-type mice, the monocyte chemoattractant protein-1(MCP-1)
increased at 3 hours after infusion, while RANTES increased after 9 hours.
TLR4, MyD88, and IRF3 knockout mice showed an abrogated neutrophil recruitment and myeloperoxidase activity
in the HS group, while the LPS response was only abolished in TLR4 and MyD88 knockouts.
Conclusions: The results of this study show that HS is capable of initiating a TLR4-dependent innate immune
response in the pancreas which is distinctly different from that induced by LPS. This inflammatory response was
mediated predominantly through IRF3- dependent pathway. Release of HS into the pancreatic duct may be one
important mediator in the pancreatic ductal defence.
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Background
Heparan sulphate (HS) glycosaminoglycans are complex
polysaccharides which consist of a repeat disaccharide
unit of uronic acid (either iduronic or glucoronic acid)
linked to a glucosamine. HS is present at the cell-tissue-
organ interface and has crucial regulatory roles in nor-
mal physiological processes, such as morphogenesis, tis-
sue repair, and host defence and is usually bound
covalently to different core proteins forming heparan
sulphate proteoglycans (HSPGs) [1,2].
The cell surface HSPGs can act as co-receptors for
soluble and insoluble ligands, soluble paracrine recep-
tors, and internalization receptors for soluble ligands
[3]. HS is found on two families of membrane-bound
proteoglycans, i.e. the syndecans and glypicans. HSPGs,
such as syndecan-1, are found on the epithelial cells lin-
ing the pancreatic duct [4]. Syndecans contain both HS
and chondroitin sulphate chains, which vary in composi-
tion and degree of modification and differ from tissue to
tissue [5].
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utmost importance to the organ itself and also to the
entire organism. It is possib l et h a tH S P G sa r ei n v o l v e d
in the immune defence of the pancreas, but their role in
pancreatitis is not well defined. However, intraductal
infusion of HS induces leukocyte cell recruitment via a
mechanism different from lipopolysaccharide (LPS) in a
rat pancreatitis model [6]. HS can be cleaved off its pro-
tein anchors by heparinases, present in the cytosol of
the pancreatic epithelial cells, and proteases (trypsin and
elastase) secreted by the pancreas. Soluble HS fragments
have emerged as endogenously modified and self-acting
as a damage associated molecular pattern (DAMP)
molecule recognized by Toll-like receptor 4 (TLR4) [7].
TLRs are also pattern recognition receptors (PRRs) and
act as surveillance receptors by recognizing numerous
endogenous and exogenous pathogen-associated mole-
cular patterns (PAMPs). HS has been proposed to act as
surveillance molecules, monitoring tissue integrity and
function [8].
T h ea i mo ft h i ss t u d yi st oi n v e s t i g a t et h er o l eo f
TLR4-signalling in HS-induced inflammatory response,
as well as its downstream regulation.
Methods
Mice
6-8-week old male C57BL/6J, TLR4
-/- ,M y D 8 8
-/- and
IRF3
-/- were used in the study. Mice were kept in appro-
priate facilities at Lund University, under specific patho-
gen-free conditions. The animals were kept under 12/12
hours light/dark regime in standard mesh cages and
handled according to the institute guidelines with
approval of the Local Animal Care Ethics Committee.
Heparan sulphate
Heparin by-products from beef lung were treated with
alkaline copper sulphate (to remove dermatan sulphate)
after papain digestion. The calcium salt was then precipi-
tated with 36% ethanol (to separate from chondroitin sul-
phate), followed by fractionation of the cetylpyridinium
complexes by solubilisation at 0.8 M NaCl to obtain HS3.
HS3 is a fraction of low sulphation (HS3, 1.00 sulphate/
unit compared to 2.40 of heparin) and has lower anti-
coagulant properties than heparin. In order to purify it
from danger signals, such as LPS, TGF-b and other con-
taminating factors, the sulphated glycosaminoglycan was
finally subjected to dissociative gel FPLC on Superose 6
(LKB-Pharmacia), which was eluted with 4 M guanidi-
nium chloride 0.05 M sodium acetate, PH 5.8, at a rate of
0.4 ml/min. The effluent was analysed for glycosamino-
glycans and pooled material was recovered by ethanol
precipitation and converted to sodium salts [9-11].
Possible LPS contamination, which is an important
consideration in the current study, was quantified by
using the limulus amoebocyte lysate assay. The analysis
showed a concentration of less than 0.5 EU/ml of LPS
in the HS preparations. This is a concentration lower
than what would be expected to influence the inflamma-
tory response [12].
Effects of HS in the in-vivo model
To determine the appropriate time to sample mice for
the second phase of the study, a time-lapse experiment
was performed with wild-type mice. The protocol for
the in vivo experiments was a modification of a pre-
viously described procedure adopted for use in mice
[13]. Briefly, the mice were anesthetized using isoflurane
(Isoba Vet., Scherling-Plough, Stockholm, Sweden), a
midline laparotomy was performed, the proximal end of
the biliary duct clamped and the biliary-pancreatic duct
was cannulated. HS 100 μl (500 μg/ml) was infused dur-
ing the course of 2 minutes using an infusion pump.
The clamp and the cannulae were then removed and
the abdomen was closed in two layers. As a negative
control, 100 μlo fP B Sa n da sap o s i t i v ec o n t r o l ,1 0 0μl
of LPS (2.5 μg/ml from Escherichia coli 0111:B4, Sigma,
St. Louis, MO, USA) were infused. The wild-type mice
(10 animals per time point) were sacrificed by exsangui-
nation after 1, 3, 6, 9, and 48 hours, and biopsies of the
duodenal lobe were harvested, snap-frozen in liquid
nitrogen and stored at -70°C until further processing.
For histological and immunostaining studies the samples
were fixed in 4% phosphate-buffered formalin.
To investigate possible signalling pathways, experi-
ments were performed on wild-type and 3 different
strains of genetically engineered mice, TLR4
-/-,
MyD88
-/- and IRF3
-/-. The in vivo model was performed
as previously described with the exception that nine
hours was used as the time point, having determined
this as the peak response time from the first experiment.
The effects of a TLR4 antagonist, eritoran (E5564;
Eisai Research Institute, Andover, MA), were studied.
Wild-type mice were categorized in three groups (eight
per group). In the first two groups, eritoran (5 mg/kg) a
synthetic analogue of lipid A and an antagonist of LPS
was injected into the tail vein one hour prior to laparot-
omy. In the last group placebo (lactose monohydrate)
was injected in the same way. The first and third (pla-
cebo) group were subjected to HS3, 500 μg/ml intraduc-
tally, while the second group only underwent
laparotomy, leaving the pancreas intact.
Immunohistochemistry
Histological and immunohistochemical (IHC) techniques
were followed according to standard procedures. Fixed
tissue biopsies were dehydrated embedded in paraffin
and 5 μm sections were cut. Primary antibodies, directed
against either neutrophils (1:300, NIMP-R14, Abcam,
Akbarshahi et al. Journal of Translational Medicine 2011, 9:219
http://www.translational-medicine.com/content/9/1/219
Page 2 of 8Cambridge, UK) or F4/80 (1:500, MCA497GA, AbD Ser-
otec, Oxford, UK) for monocytes, macrophages, and cer-
tain subpopulations of dendritic cells were used to
visualize inflammatory cells. The slides were then incu-
bated with appropriate secondary antibodies (1:400,
ABC Vectastain, Vector Laboratories, Burlingame, CA,
USA) and visualized using 3, 3’-diaminobenzidine (DAB,
DAB peroxidase substrate Kit, Vectastain; Vector
Laboratories). H2O2/methanol, levamisol (DakoCytoma-
tion) and avidin/biotin blocking (Vector Laboratories)
were used to block the endogenous peroxidase, phos-
phatase and biotin, respectively.
Specificity of the antibodies for neutrophils and mono-
cytes was confirmed by comparisons to morphological
characters of the cell types. The slides were photo-
graphed using a Nikon Eclipse E800 microscope, Olym-
pus DP70 camera and Nis elements software. The total
number of neutrophils and monocytes in the entire sec-
tions was calculated and the total area was measured
using ImageJ 1.38 (National Institute of Health, USA).
Cell counts were expressed as total cells per mm
2 tissue.
Myeloperoxidase activity
Myeloperoxidase (MPO) activity was measured according
to Koike et al [14], with some modifications, as briefly out-
lined below. Tissue samples were homogenized and
washed in gradually increasing concentrations of PBS. The
supernatant was reacted with 3,3’,5,5’-tetramethylbenzi-
dine in the presence of hydrogen peroxide (H2O2)a n dw a s
subsequently stopped by addition of sulphuric acid (2M,
H2SO4), after which the colour shift was analysed in a
spectrophotometer at 450 nm (and 540 nm as control
wavelength). Horseradish peroxidase (HRP) was used as
standard and the results were expressed as μU/ml.
Cytokine production
-Enzyme-linked immunosorbent assay (ELISA) was used
to determine concentrations of MCP-1, KC, MIP -2 and
RANTES of pancreas homogenates. Homogenates were
prepared by homogenizing pancreatic tissue in HEPES
buffer (20 mM, pH 7.4), supplemented with EDTA (1.5
mM) and protease inhibitors (Complete, Roche Diagnos-
tics GmbH, Mannheim, Germany). Commercially avail-
able ELISA kits were used according to the
manufacturer’s instructions (R&D Systems, Minneapolis,
MN, USA).
Cytokine array panel
Mouse cytokine array kit (R&D Systems, Minneapolis,
USA) was used to analyse 40 different murine cytokines.
Carefully selected capture antibodies have been spotted
in duplicate on nitrocellulose membranes. Samples were
mixed with a cocktail of biotinylated detection antibo-
dies. The sample/antibody mixture was then incubated
with the array. Chemiluminescent detection reagent was
added and the signal was read.
Statistics
The statistical analysis of the data was performed using the
Mann-Whitney U-test. A p-value < 0.05 was considered
statistically significant and no corrections for multiple
comparisons were made. All statistical analyses were done
using SPSS 16.0 (SPSS Inc., Chicago, Ill., USA). Outliers
were defined as > 1.5 times the inter-quartile range and
excluded from the figures, but included in all calculations.
All comparisons in the treatment groups were made
to the PBS control at the corresponding time point.
Results
HS induces neutrophil infiltration and increased MPO
activity in C57BL/6J wild-type mice
Immunohistochemical analysis of HS-infused pancreas
showed a marked infiltration of neutrophils into the tis-
sue after 9 hours (Figure 1A). LPS induced neutrophil
recruitment into the pancreatic tissue to a higher extent
(Figure 1B). No significant neutrophil staining was
observed in pancreatic tissue from PBS-infused organs
(Figure 1C). HS-treated organs contained a 3-fold
increase in tissue neutrophil recruitment, measured as
number of cells per mm
2 in pancreatic tissue, only 9
hours following the HS challenge as compared to the
PBS group (p < 0.001; Figure 1D). The LPS-treated mice
showed an increase of the neutrophil infiltration as early
as at 3 hours. A further increase was noted 6 and 9
hours after the treatment (p < 0.001; Figure 1D).
Measurement of MPO activity demonstrated a similar
pattern as neutrophil sequestration. MPO activity was
increased at 9 hours in the HS group (mean 1.55 μU/ml,
SE 0.29) as compared to the PBS group (mean 0.40 μU/
ml, SE 0.17; p < 0.05). LPS caused an increase at 3, 6 and
9 hours (mean 8.11 μU/ml, SE 2.32; p < 0.001; Figure 1E).
Macrophage infiltration was also evaluated, but due to
the low counts of F4/80 positive cells in each slide, no
significant difference was found (data not shown).
The results showed that HS is capable of initiating an
inflammatory response in the pancreatic duct, though
less pronounced than seen following LPS.
TLR4 and IRF3 are involved in HS-mediated neutrophil
infiltration measured as MPO activity
HS as well as LPS induced significant amounts of MPO
activity in the pancreatic tissue of wild-type mice (Figure
2; p < 0.05). In order to determine the role of the TLR4
signalling pathways in the HS-induced inflammatory
response, TLR4
-/- as well as the adaptor protein,
MyD88
-/- and the transcription factor, IRF3
-/- were used.
MPO activity correlated strongly with neutrophil recruit-
ment into the tissue (Figure 1E). MPO activity was
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-/- mice in both HS- and LPS-treated
animals, as compared to the response in the wild-type
mouse. Similarly, LPS and HS did not induce an inflamma-
tory response in MyD88
-/- mice (Figure 2). Interestingly,
whereas the HS response in IRF3
-/- mice was completely
abrogated, these mice still mounted a strong response to
LPS (200-higher than HS-treated IRF3
-/- animals).
The above results show that TLR4-mediated HS
inflammation is regulated by IRF3.
Eritoran inhibits the increased MPO production in the HS-
treated mouse pancreas
To investigate the mechanism by which HS activates
TLR4, eritoran, a synthetic Lipid A analogue, which
binds to TLR4/MD2, was used. This Lipid IVA has pre-
viously been shown to compete with Lipid A in the
binding to MD2 and inhibits LPS-mediated inflamma-
tory responses [15].
The MD2 dependence in HS-activated tissues was
thus investigated using eritoran. Interestingly, the MPO
activity of HS-treated wild-type mouse pancreas was
completely abrogated by eritoran pretreatment (mean:
0.04177 ± 0.00405; p < 0.005) as compared to placebo
(mean: 7.805 ± 2.674; Figure 3). Eritoran treatment
alone did not induce any inflammatory responses.
Chemoattractants
In search for the involved chemoattractants in the
inflammatory process, pancreatic samples of the time-
response study were studied for the most well-known
chemoattractants of neutrophils and monocytes: the
monocyte chemoattractant protein-1 (MCP-1), keratino-
cyte chemoattractant (KC), and macrophage inflamma-
tory protein-2 (MIP-2).
MCP-1 significantly increased at 3 hours after infusion
of HS (p < 0.001; Figure 4A). LPS induced a more
A.                                                                         B.                                                                   C. 
             
 
D.                                                                                                                    E.                                                                                              
           
Figure 1 Neutrophil infiltration into pancreatic tissue nine hours after administration of heparan sulphate (A), lipopolysaccharide (B)
and PBS (C), illustrated by NIMP-R14 positive cells. Neutrophil sequestration (D) and MPO activity (E) during 48 hours after infusion is
illustrated. Neutrophil recruitment significantly increased at 3, 6 and 9 hours in the LPS treated and at 9 hours in the HS treated group
compared to the PBS group. *P < 0.05 **P < 0.01 ***P < 0.001 PBS, phosphate-buffered saline, HS, heparan sulphate, LPS, lipopolysaccharide and
healthy refers to untreated animals.
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hours after stimulation (p < 0.001; Figure 4A). The con-
centration thereafter decreased and reached background
levels 9 hours after infusion.
The concentration of KC in the pancreatic homoge-
nates of the HS-treated group only modestly increased
after 1 hour of stimulation, but was significantly differ-
ent from what was seen in animals administered PBS (p
< 0.05; Figure 4B). LPS, on the other hand, induced a
pronounced KC production, peaking 3 hours after sti-
mulation (p < 0.001).
Neither HS nor LPS infusion caused any significant
change in MIP-2 levels within the pancreas (data not
shown).
Cytokine array panel for IRF3
-/- animals
In order to provide an overview of the cytokine profile
of wild-type and IRF3
-/- mice, we performed a cytokine
array panel on the pancreas homogenates. From each
group, one sample was chosen and the assay was pre-
pared with the same amount of sample protein.
The array showed a difference between HS-treated
IRF3 and WT mice regarding two cytokines: RANTES
and IP10. Both cytokines were absent in the HS-treated
IRF3
-/- mice, while present to a lesser extent in the LPS
group.
Time response samples were studied and no demon-
strable differences were found in the HS-treated wild-
type samples prior to nine hours (Figure 5A).
To confirm the results of the cytokine array, RANTES
was measured in all samples of the wild-types, as well as
in TLR4
-/- and IRF3
-/- samples. RANTES was signifi-
cantly increased in the HS-treated wild-type, but not in
TLR4
-/- and IRF3
-/- animals, compared to the PBS
g r o u p( p<0 . 0 0 1 ) .M o r e o v e r ,c o m p a r e dt ot h eP B S
group, the LPS-treated group had a rise in wild-type
and IRF3
-/- mice, but not in TLR4
-/- mice (Figure 5B).
Discussion
In this study we focused on the role of TLR4 and its
downstream signalling in the HS-induced inflammatory
response in the pancreas. We investigated the inflamma-
tory response by HS in vivo. We showed that the
inflammatory response in pancreas exposed to HS is
TLR4-mediated. Furthermore, we extended the investi-
gation to analyse the role of the adaptor protein MyD88
and the transcription factor IRF3 in this inflammatory
response. The rationale for studying IRF3 comes from
studies in the urinary tract mucosa where uropathogenic
E. coli (UPEC) induces strong inflammation in a MyD88
Figure 3 Pre-treatment of mice with the TLR4 antagonist,
eritoran significantly decreased MPO activity in HS treated
mice as compared to placebo. ***P < 0.001.
A.                                                                                             
 
B. 
Figure 4 Levels of MCP-1 (A) and KC (B) measured in HS, PBS
and LPS treated mice at various time points after intraductal
infusion.* P < 0.05 **P < 0.01 ***P < 0.001.
Figure 2 Increased MPO activity in WT mice treated with HS.
This inflammatory response is abolished in the TLR4, MyD88 and
IRF3 knockouts. *P < 0.05 **P < 0.01 ***P < 0.001.
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also CD14 independent, showing activation of the
mucosa by UPEC, in an LPS independent fashion [17].
Endogenous TLR activators from degraded extracellu-
lar matrix, such as biglycans, hyaluronans, HS and versi-
cans, belong to molecules of the DAMP classification
[7]. Biglycans and oligosaccharides of hyaluronan signal
through TLR4 and can stimulate macrophages to pro-
duce large amounts of tumour necrosis factor-alpha
(TNF-a) and MIP-2. Furthermore, antigen presenting
cells such as dendritic cells (DC) were also activated by
low molecular weight fragmentation products of the
polysaccharides of hyaluronan through TLR4 [18,19].
Fragments of HSPG stimulate murine DC via TLR4,
leading to DC maturation manifested by expression of
cell surface molecules that aid in T lymphocyte stimula-
tion [8]. This suggests that TLRs may be crucial as sen-
sors of vital danger signals and tissue integrity [8].
To investigate if HS really acts through the TLR4 sys-
tem, both an antagonist and animals specifically targeted
in TLR4, or its signalling pathway, were used. Eritoran, a
synthetic competitive inhibitor of LPS-induced inflam-
matory responses, was used. In vitro and in vivo studies
have previously shown that this substance dose-
dependently inhibits LPS-mediated activation of immune
cells [20]. Eritoran abrogated the HS- induced inflam-
matory response, indicating that HS-induced dimeriza-
tion of TLR4/MD2 is crucial for the inflammatory
response in vivo. Whether HS binds directly to the
receptor, acts via a co-receptor, or a mediator such as
CD14 or CD 44, is not clear. This inhibitory effect may
be due to binding of HS to the same position as eri-
toran, or a conformational change in the binding site
after using eritoran, with the result that HS cannot bind
and initiate signalling.
Af u r t h e rp r o o fo ft h ei n v o l v e m e n to fT L R 4a n di t s
signal transduction is the data obtained in TLR4
-/- ani-
mals, where the recruitment of neutrophils was abro-
gated. Furthermore, TLR4 involves several adaptor
molecules that can lead to the initiation of inflammatory
response, including the MyD88 and TRIF pathways.
MyD88 is a cytosolic adaptor protein in the Toll-like
receptor signalling pathway, upstream of the transloca-
tion of NF-B into the nucleus. TRIF is the well-charac-
terized adaptor in TLR4 signalling, which has been
shown to be related to the induction of late signalling.
Initiation of the TRIF-dependent pathway leads to IRF3
translocation into the nucleus, and transcription of
interferon alpha and beta, as well as other interferon-
induced genes [21,22].
This study is the first to show that HS-induced
inflammatory response is executed through the IRF3
pathway. Neutrophil recruitment and MPO activity in
the pancreas were abolished in MyD88
-/- and IRF3
-/-
mice exposed to HS. However, LPS signalling was com-
pletely abrogated in MyD88
-/- but not in IRF3
-/- mice.
Thus, the DAMP signal by HS promotes inflammation
in the pancreatic duct differently than LPS.
In search for downstream signalling events, well-docu-
mented chemoattractants of neutrophils, KC and MIP-2,
were analysed. To our surprise, no change of MIP-2,
and only a slight, very early change of KC were noted
after one hour. The KC change may be due to the very
narrow variation rather than a relevant biological event.
However MCP-1, which mainly recruits macrophages,
did increase. This confirms previous reports that have
suggested that leukocyte recruitment can be regulated
by MCP-1 [23,24].
MCP-1 can be induced in both MyD88-dependent and
-independent pathways. The IRF3 knockdown decreased
the transcription of many chemokines including MCP-1
[25].
MCP-1 levels demonstrated a significant increase after
three hours in the HS-treated mice. However, the
macrophage counts were too low to detect significant
differences between the groups.
The chemokines recruiting neutrophils activated
through the IRF3 pathway are not well known. A
A.         
                   
 
B.  
Figure 5 RANTES measured at various time points in wild type
mice (A). The level of RANTES after 9 hours of infusion of HS, PBS
and LPS in wild type, TLR4 and IRF3 knockout mice (B). ***P < 0.001.
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decreased in the IRF3
-/- by HS. A confirmation using
ELISA showed a significant rise in the RANTES level,
nine hours after the treatment with HS. This confirms
earlier studies that have shown a role for RANTES in
the neutrophil trafficking during inflammation [26].
In our studies HS induces a rather weak response as
compared to LPS. This is what could be expected from
a low-grade, but sustained response. It could be argued
that this response is intended to recruit a low, but ade-
quate number of monocytes and neutrophils to the site
of cell injury. LPS, on the other hand, triggers a power-
ful acute response to invading pathogens where much
higher amounts of inflammatory cells are recruited. As
s h o w ni nt h ec u r r e n ts t u d y , LPS attracts and subse-
quently activates a large number of neutrophils, just as
would be required in response to a bacterial infection.
Our findings are in agreement with several previous
reports of TLR-mediated pro-inflammatory activation
cascades by DAMPs. The activation of TLR4 system by
released HS leads to recruitment of leucocyte and acti-
vation of fibroblasts which is required for tissue repair.
We hypothesize that, this response is a defence mechan-
ism to remove damaged cells and further protect against
activated pancreatic enzymes in the pancreatic duct.
Conclusions
In summary, we have shown that HS is capable of initi-
ating an innate immune response in the murine pan-
creas, distinct from that induced by LPS. The response
is TLR4-mediated and involves both MyD88-dependent
and -independent pathways. Interestingly, the HS-
induced inflammation was IRF3 dependent, indicating a
role of the interferon pathway in host defence response
by HS. The new knowledge of an IRF3 dependent path-
way by HS may prove clinically important when
attempting to treat inflammations of the pancreas, with
interferon signalling antagonists.
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